You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Carcinoma, Non-Small-Cell Lung

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

TRAcking Non-small Cell Lung Cancer Evolution Through Therapy

Not yet recruiting
  • Lung Cancer, Non-small Cell
  • Small Cell Lung Cancer
    • (no location specified)
    Nov 16, 2022

    China With Non-Small-Cell Lung Cancer That is Unable to be

    Not yet recruiting
    • Carcinoma, Non-Small-Cell Lung
      • (no location specified)
      May 16, 2023

      NSCLC, Carcinoma, Small Cell Lung, Carcinoma, Thymic Trial run by the National Cancer Institute (NCI) (AZD6244, MK-2206,

      Active, not recruiting
      • Carcinoma, Non-Small-Cell Lung
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Aug 24, 2022

      NSCLC Trial in Guangzhou (Surufatinib,Toripalimab,Pemetrexed,Carboplatin/Cisplatin)

      Recruiting
      • Carcinoma, Non-Small-Cell Lung
      • Guangzhou, Guang Dong, China
        Sun Yat-sen University Cancer Center
      Nov 3, 2022

      NSCLC, NSCLC, Nonsmall Cell Lung Cancer Trial in Saint Louis (Nintedanib)

      Active, not recruiting
      Has Results
      • Carcinoma, Non-Small-Cell Lung
      • +2 more
      • Saint Louis, Missouri
        Washington University School of Medicine
      Jan 3, 2023

      Imfinzi/Imjudo NSCLC Japan PMS_Japan Post-Marketing Surveillance

      Not yet recruiting
      • Carcinoma, Non-Small-Cell Lung
        • (no location specified)
        Apr 21, 2023

        NSCLC Trial (Pembrolizumab, Docetaxel)

        Active, not recruiting
        Has Results
        • Carcinoma, Non-Small-Cell Lung
        • (no location specified)
        Aug 18, 2022

        Circulating Tumor DNA and T Cell Repertoire Predict

        Not yet recruiting
        • Carcinoma, Non-Small-Cell Lung
        • Brain Metastases
        • Whole-brain radiotherapy
        • Wuhan, Hubei, China
          Union hospital
        Feb 12, 2023

        NSCLC, Metastatic Lung Non-Small Cell Carcinoma, Non Small Cell Lung Cancer Trial (Palliative Radiotherapy: 5 x 4Gy, chemo +

        Not yet recruiting
        • Carcinoma, Non-Small-Cell Lung
        • +2 more
        • Palliative Radiotherapy: 5 x 4Gy
        • chemotherapy + immune checkpoint inhibitors
        • (no location specified)
        Jun 27, 2022

        NSCLC Trial (JDQ443)

        Not yet recruiting
        • NSCLC
        • (no location specified)
        Feb 2, 2023

        NSCLC Trial in Xinxiang (CCCR-NK92 cells)

        Enrolling by invitation
        • Non-small Cell Lung Cancer
        • CCCR-NK92 cells
        • Xinxiang, Henan, China
          The first Affiliated Hospital of Xinxiang Medical University
        Aug 31, 2022

        Nivolumab, Ipilimumab, and Chemotherapy in Non-small Cell Lung

        Not yet recruiting
        • Carcinoma, Non-Small-Cell Lung
          • Athens, Greece
            Local Institution - 0001
          Oct 26, 2022

          NSCLC, EGF-R Positive NSCLC Trial in Wuxi (Parimparib, Chemotherapy drug, Targeted Therapy Agent)

          Recruiting
          • Carcinoma, Non-Small-Cell Lung
          • EGF-R Positive Non-Small Cell Lung Cancer
          • Wuxi, Jiangsu, China
            Affiliated Hospital of Jiangnan University
          Jan 30, 2023

          NSCLC Trial (Mobocertinib 160 mg)

          Approved for marketing
          • Carcinoma, Non-Small-Cell Lung
          • Mobocertinib 160 mg
          • (no location specified)
          Sep 28, 2022

          NSCLC, Immune Checkpoint Inhibitors Trial in Seoul (F-18 FDG PET/CT)

          Recruiting
          • Carcinoma, Non-Small-Cell Lung
          • Immune Checkpoint Inhibitors
          • F-18 FDG PET/CT
          • Seoul, Korea, Republic of
            Samsung Medical Center
          Jun 15, 2022

          NSCLC, Carcinoma, Renal Cell, Esophageal Squamous Cell Carcinoma Trial (QEQ278)

          Not yet recruiting
          • Carcinoma, Non-Small-Cell Lung
          • +3 more
          • QEQ278
          • (no location specified)
          Jul 14, 2022

          NSCLC Trial

          Not yet recruiting
          • Non-small Cell Lung Cancer
            • (no location specified)
            Sep 14, 2022

            Immune Checkpoint Inhibitors in Non-Small Cell Lung Carcinoma

            Active, not recruiting
            • Non Small Cell Lung Cancer
            • Immune signature in serum associated to the metabolic signature
            • Meta-genomic signature of intestinal flora
            • La Tronche, Isère, France
              University Hospital, Grenoble
            Jan 6, 2023

            NSCLC, Antineoplastic Agents Trial in Edmonton (Experimental intervention)

            Active, not recruiting
            • Carcinoma, Non-Small-Cell Lung
            • Antineoplastic Agents
            • Experimental intervention
            • Edmonton, Alberta, Canada
              Cross Cancer Institute
            May 23, 2022

            Examination of Trends in Non-Small Cell Lung Cancer Patients'

            Not yet recruiting
            • Non-Small Cell Lung Cancer
              • (no location specified)
              Mar 10, 2023

              d To Treat People With Non-Small Cell Lung Cancer

              Recruiting
              • Non-small Cell Lung Cancer (NSCLC)
              • Tokyo, Japan
                Takeda Selected Site
              Oct 13, 2022

              DevelopingShared Decision Making Tool for Surgically Removed

              Recruiting
              • Lung Non-Small Cell Carcinoma
              • Discussion
              • Questionnaire Administration
              • Rochester, Minnesota
                Mayo Clinic in Rochester
              Jan 4, 2023

              The Use of Molecular Radiogenomics in Non-small Cell Lung Cancer

              Not yet recruiting
              • Lung Cancer
                • (no location specified)
                Sep 13, 2022

                A Real World Study of Ensartinib in Advanced ALK-positive NSCLC

                Recruiting
                • Carcinoma, Non-Small-Cell Lung
                • +2 more
                • Beijing, Beijing, China
                  Department of Respiratory and Critical Care Medicine, Peking Uni
                Aug 10, 2022

                Identify Resected Non-small-cell Lung Cancer With High Risk of

                Recruiting
                • Non-small Cell Lung Cancer Stage IIIA
                • Resected non small cell lung cancer
                • Toulouse, France
                  Julien MAZIERES
                Feb 8, 2023